Another anti-tumor inhibitor, quercetin, showed effective inhibition of AURKB pro-tumorigenic activities by directly binding to AURKB under in vitro and in vivo conditions in JBC Cl41 and A549 lung cancer cells and A549 xenografts, respectively [63]. The gene discussed is AURKB; the disease is lung carcinoma.